<DOC>
	<DOCNO>NCT03106766</DOCNO>
	<brief_summary>To assess facial acne vulgaris clinical psychological outcome measure difference lesion count , investigator global assessment , subject quality life score 6 month adult female treat Next Science™ acne cream 2x Next Science™ acne cream 1x double blind manner .</brief_summary>
	<brief_title>Six Months Evaluation Next Science Acne Creams Facial Acne Adult Females .</brief_title>
	<detailed_description>This 6-month , single-site , double-blind , control study 20 female subject mild moderate facial acne . Subjects randomize 1:1 apply either topical Next Science™ acne cream 2x Next Science™ acne cream 1x daily . Subjects evaluate clinical acne quality life outcome baseline , 6 , 12 , 18 24 week .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>1 . Female age 18 2 . Has 20 inflammatory lesion face ( papule pustule ) determine qualified examiner Start Treatment . 3 . In area treat , significant facial dermatological condition acne ( determined investigator ) would interfere study treatment procedure 4 . Is willing able discontinue use baseline acne treatment duration trial participation 5 . Agrees refrain professional facial treatment trial participation . 6 . Agrees avoid tan booth use minimize sun exposure trial participation . 7 . Is willing able follow instruction procedure include attend schedule study visit , require adequate transportation study site 8 . Is able read , understand sign inform consent document communicate study staff investigator . 1 . Has 2 nodules/cystic acne lesion face 2 . Has history significant reaction topical acne treatment , know allergy hypersensitivity list ingredient 3 . Has history skin malignancy 4 . Has use systemic medication ( include antibiotic , estrogen , retinoids ) primarily treatment acne 21 day prior randomization . 5 . Has use estrogen primarily treatment acne 21 day prior randomization ( estrogens prescribe reason allow stable least 30 day prior randomization ) . 6 . Has professional facial treatment 14 day prior randomization . 7 . Has receive investigational treatment 30 day prior randomization . 8 . Have significant medical problem issue would , investigator 's judgment , affect suitability participation trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>